International Agency for Res on Cancer

Hilary A. Robbins

Scientist7 Sept 2026reporter.nih.gov

Partha Basu

Head, early detection & prev branch3 Sept 2026reporter.nih.gov

Mirlinda Kachuri

11 Aug 2026reporter.nih.gov

Mattias Alexander Johansson

Scientist11 Aug 2026reporter.nih.gov

Mahdi SHEIKH

11 Jun 2026reporter.nih.gov

National Cancer Institute

R01Early Biomarkers for HPV-Driven Cancers: Modeling Risks and ScreeningR01CA307572US$322.1k2026–20317 Sept 2026reporter.nih.gov

National Cancer Institute

R37A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICsR37CA275824US$301.2k2023–20283 Sept 2026reporter.nih.gov

National Cancer Institute

R37A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICsR37CA275824US$95.6k2023–20282 Sept 2026reporter.nih.gov

National Cancer Institute

R37A novel, one stop, affordable, point of care and artificial intelligence supported system of screening, triage and treatment selection for cervical cancer and precancer in the LMICsR37CA275824US$147.8k2023–202824 Aug 2026reporter.nih.gov

National Cancer Institute

R01Proteogenomic framework for precision lung cancer screeningR01CA316401US$546.5k2026–203111 Aug 2026reporter.nih.gov

National Cancer Institute

U01The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer riskU01CA289226US$35.8k2024–202911 Jun 2026reporter.nih.gov

National Cancer Institute

U01The Opioid Cohort Consortium (OPICO) to investigate the effects of using opioids on cancer riskU01CA289226US$522.7k2024–20291 May 2026reporter.nih.gov